Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blandine Guffroy

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Blood Advances|April 12, 2021
CDX2 regulates ACE expression in blood development and leukemia cellsReine El Omar, Emmanuelle Julien, Katia Biasch, et al.
American Journal of Hematology|May 17, 2026
CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network StudyFrançois Bouille, Marine Baron, Roch Houot, et al.
American Journal of Hematology|September 18, 2020
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)Monica Poiani, Myriam Labopin, Giorgia Battipaglia, et al.
Blood Advances|January 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA studyXavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros, et al.
Blood Advances|January 5, 2024
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, et al.
British Journal of Haematology|February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMTDonal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.
Bone Marrow Transplantation|November 19, 2020
Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
Haematologica|June 20, 2024
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registryCharles Herbaux, Caroline Bret, Emmanuel Bachy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 4, 2021
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort studyFrançois Danion, Céline Duval, François Séverac, et al.
Blood Advances|October 22, 2025
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryFederico Erbella, Emmannuel Bachy, Guillaume Cartron, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Blood Advances|April 12, 2021
CDX2 regulates ACE expression in blood development and leukemia cellsReine El Omar, Emmanuelle Julien, Katia Biasch, et al.
American Journal of Hematology|May 17, 2026
CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network StudyFrançois Bouille, Marine Baron, Roch Houot, et al.
American Journal of Hematology|September 18, 2020
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)Monica Poiani, Myriam Labopin, Giorgia Battipaglia, et al.
Blood Advances|January 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA studyXavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros, et al.
Blood Advances|January 5, 2024
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, et al.
British Journal of Haematology|February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMTDonal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.
Bone Marrow Transplantation|November 19, 2020
Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
Haematologica|June 20, 2024
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registryCharles Herbaux, Caroline Bret, Emmanuel Bachy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 4, 2021
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort studyFrançois Danion, Céline Duval, François Séverac, et al.
Blood Advances|October 22, 2025
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryFederico Erbella, Emmannuel Bachy, Guillaume Cartron, et al.
Pageof 3